Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dermot McGovern

Showing results (41-50 of 57) with videos related to

Pageof 6
Sort By:
Inflammatory Bowel Diseases|June 24, 2011
Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interfaceLaura L Presley, Jingxiao Ye, Xiaoxiao Li, et al.
Inflammatory Bowel Diseases|June 9, 2021
Serum Analyte Profiles Associated With Crohn's Disease and Disease LocationGabrielle Boucher, Alexandre Paradis, Geneviève Chabot-Roy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.
Gut|December 25, 2012
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European ProjectIsabelle Cleynen, Juan R González, Carolina Figueroa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
The American Journal of Gastroenterology|June 11, 2009
Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repositoryMamatha Bhat, Geoffrey C Nguyen, Pierre Pare, et al.
Gastroenterology|October 11, 2019
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's DiseaseAleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, et al.
Inflammatory Bowel Diseases|December 23, 2017
IBD Serology and Disease Outcomes in African Americans With Crohn's DiseaseMadeline Bertha, Arthi Vasantharoopan, Archana Kumar, et al.
Clinical and Translational Gastroenterology|November 3, 2017
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter StudyLiset Westera, Tanja van Viegen, Jenny Jeyarajah, et al.
Pageof 6

Showing results (41-50 of 57) with videos related to

Sort By:
Pageof 6
Inflammatory Bowel Diseases|June 24, 2011
Host-microbe relationships in inflammatory bowel disease detected by bacterial and metaproteomic analysis of the mucosal-luminal interfaceLaura L Presley, Jingxiao Ye, Xiaoxiao Li, et al.
Inflammatory Bowel Diseases|June 9, 2021
Serum Analyte Profiles Associated With Crohn's Disease and Disease LocationGabrielle Boucher, Alexandre Paradis, Geneviève Chabot-Roy, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|November 7, 2022
Comparative Safety and Effectiveness of Biologic Therapy for Crohn's Disease: A CA-IBD Cohort StudySiddharth Singh, Jihoon Kim, Jiyu Luo, et al.
Gut|December 25, 2012
Genetic factors conferring an increased susceptibility to develop Crohn's disease also influence disease phenotype: results from the IBDchip European ProjectIsabelle Cleynen, Juan R González, Carolina Figueroa, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|June 1, 2022
Effectiveness and Safety of Biologic Therapy in Hispanic Vs Non-Hispanic Patients With Inflammatory Bowel Diseases: A CA-IBD Cohort StudyNghia H Nguyen, Jiyu Luo, Paulina Paul, et al.
Journal of Crohn'S & Colitis|April 28, 2025
Expert recommendations to standardize transcriptomic analysis in inflammatory bowel disease clinical trialsBryan Linggi, Salas Azucena, Boyd Steere, et al.
The American Journal of Gastroenterology|June 11, 2009
Phenotypic and genotypic characteristics of inflammatory bowel disease in French Canadians: comparison with a large North American repositoryMamatha Bhat, Geoffrey C Nguyen, Pierre Pare, et al.
Gastroenterology|October 11, 2019
HLA-DQA1*05 Carriage Associated With Development of Anti-Drug Antibodies to Infliximab and Adalimumab in Patients With Crohn's DiseaseAleksejs Sazonovs, Nicholas A Kennedy, Loukas Moutsianas, et al.
Inflammatory Bowel Diseases|December 23, 2017
IBD Serology and Disease Outcomes in African Americans With Crohn's DiseaseMadeline Bertha, Arthi Vasantharoopan, Archana Kumar, et al.
Clinical and Translational Gastroenterology|November 3, 2017
Centrally Determined Standardization of Flow Cytometry Methods Reduces Interlaboratory Variation in a Prospective Multicenter StudyLiset Westera, Tanja van Viegen, Jenny Jeyarajah, et al.
Pageof 6